ARG
Growth Failure
Johann Wolfgang Goethe University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Growth Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
17-beta-estradiol Johann Wolfgang Goethe University Hospital | Phase 4 | BB |
Genotropin Johann Wolfgang Goethe University Hospital | Phase 4 | BB |
Clonidine Johann Wolfgang Goethe University Hospital | Phase 4 | B |
Same molecule, other indications
ARG is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →